AbCellera Biologics ABCL 深 沪
已收盘 09-19 16:00:00 美东时间
4.51
-0.210
-4.45%
华盛通- 最 高4.75
- 今 开4.68
- 成交量 596.53万股
- 最 低 4.49
- 昨 收 4.72
- 总市值 13.44亿
- 52周最高 5.82
- 市盈率 静 --
- 换手率 2.00%
- 52周最低 1.8906
- 委 比 -60.79%
- 总股本 2.98亿
- 历史最高 71.91
- 量 比 1.50
- 振 幅 5.51%
- 历史最低 1.8906
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AbbVie Presents Phase 2 Data On Epcoritamab For Relapsed/Refractory DLBCL Showing Manageable Safety Profile
Data presented at 13th Society of Hematologic Oncology (SOHO) Annual MeetingNORTH CHICAGO, Ill., Sept. 3, 2025 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced updated results from the Phase 2 EPCORE® NHL-6 trial
09-03 20:38
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
08-19 01:35
Expert Outlook: AbCellera Biologics Through The Eyes Of 4 Analysts
4 analysts have expressed a variety of opinions on AbCellera Biologics (NASDAQ:...
08-09 02:02
Stifel Maintains Buy on AbCellera Biologics, Lowers Price Target to $7
Stifel analyst Stephen Willey maintains AbCellera Biologics (NASDAQ:ABCL) with a Buy and lowers the price target from $8 to $7.
08-08 21:41
AbCellera Biologics Q2 EPS $(0.12) Beats $(0.15) Estimate, Sales $17.084M Beat $5.824M Estimate
AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 21.05 percent. This is a 7.69 percent increase over losses of $(0.13) per share
08-08 04:33
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on ...
07-21 22:16
美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
Leerink Partners Assumes AbCellera Biologics at Outperform, Announces Price Target of $5
Leerink Partners analyst Faisal Khurshid assumes AbCellera Biologics (NASDAQ:ABCL) with a Outperform rating and announces Price Target of $5.
07-07 20:39
